Differences in Cdk4 and Cdk6 function in primary mouse astrocytes

被引：0
|
作者：
Ericson, KK [1 ]
Gocheva, V [1 ]
Slomiany, P [1 ]
Udoeyop, I [1 ]
Grossel, MJ [1 ]
机构：
[1] Connecticut Coll, New London, CT 06320 USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
2465
引用
收藏
页码：438A / 438A
页数：1
相关论文
共 50 条
  • [21] Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions
    Poomsawat, Sopee
    Buajeeb, Waranun
    Khovidhunkit, Siribang-on
    Punyasingh, Jirapa
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2010, 39 (10) : 793 - 799
  • [22] BTX-9341, a bifunctional degrader of CDK4 and CDK6 for glioblastoma multiforme
    Majeski, Hannah
    Chahal, Kirti
    Okano, Akinori
    Pasis, Angela
    Carlson, Casey
    Shakya, Arvind
    Liu, Qiao
    Huang, Shenlin
    Chourasia, Aparajita Hoskote
    Fung, Leah
    CANCER RESEARCH, 2024, 84 (06)
  • [23] Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer
    Asciolla, James J.
    Wu, Xuewei
    Adamopoulos, Christos
    Gavathiotis, Evripidis
    Poulikakos, Poulikos I.
    NATURE CANCER, 2025, 6 (01) : 24 - 40
  • [24] CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma
    Sun, Ran
    Wang, Xuemei
    Zhang, Leichao
    Gu, Yu
    Yang, Shaojuan
    Wang, Liping
    Wang, Xueju
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
    Poulikakos, P.
    Wu, X.
    Yang, X.
    Xiong, Y.
    Ito, T.
    Ahmed, T.
    Karoulia, Z.
    Adamopoulos, C.
    Li, R.
    Wang, H.
    Wang, L.
    Xie, L.
    Liu, J.
    Ueberheide, B.
    Aaronson, S.
    Chen, X.
    Buchanan, S.
    Sellers, W.
    Jin, J.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S5 - S5
  • [26] Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
    Xuewei Wu
    Xiaobao Yang
    Yan Xiong
    Ruitong Li
    Takahiro Ito
    Tamer A. Ahmed
    Zoi Karoulia
    Christos Adamopoulos
    Hong Wang
    Li Wang
    Ling Xie
    Jing Liu
    Beatrix Ueberheide
    Stuart A. Aaronson
    Xian Chen
    Sean G. Buchanan
    William R. Sellers
    Jian Jin
    Poulikos I. Poulikakos
    Nature Cancer, 2021, 2 : 429 - 443
  • [27] Different expression of CDK4 and CDK6 among B-cell non-Hodgkin lymphomas as a marker of sensitivity to CDK4/6 inhibitors
    Vesela, D.
    Kupcova, K.
    Klener, P.
    Havranek, O.
    Krystof, V.
    Jorda, R.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S78 - S78
  • [28] Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
    Wu, Xuewei
    Yang, Xiaobao
    Xiong, Yan
    Li, Ruitong
    Ito, Takahiro
    Ahmed, Tamer A.
    Karoulia, Zoi
    Adamopoulos, Christos
    Wang, Hong
    Wang, Li
    Xie, Ling
    Liu, Jing
    Ueberheide, Beatrix
    Aaronson, Stuart A.
    Chen, Xian
    Buchanan, Sean G.
    Sellers, William R.
    Jin, Jian
    Poulikakos, Poulikos I.
    NATURE CANCER, 2021, 2 (04) : 429 - +
  • [29] Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme
    Lam, PYP
    Ditomaso, E
    Ng, HK
    Pang, JCS
    Roussel, MF
    Hjelm, NM
    BRITISH JOURNAL OF NEUROSURGERY, 2000, 14 (01) : 28 - 32
  • [30] A NOVEL CYTOPLASMIC SUBSTRATE FOR CDK4 AND CDK6 IN NORMAL AND MALIGNANT EPITHELIAL DERIVED CELLS
    KWON, TK
    BUCHHOLZ, MA
    GABRIELSON, EW
    NORDIN, AA
    ONCOGENE, 1995, 11 (10) : 2077 - 2083
12345